The Centers for Disease Control and Prevention (CDC) Vaccine Adverse Event Reporting System (VAERS), is the principal government-funded system for reporting adverse vaccine reactions in the U.S. New data showing a total of 1,307,928 reports of adverse events following COVID-19 vaccines were submitted between December 14, 2020, and June 24, 2022. There was a total of 29,162 reports of deaths, an increase of 131 over last week, and 241,226 serious injuries, including deaths, during the same time period — an increase of 1,004 compared with last week. Of the 29,162 reported deaths, 18,885 cases are attributed to Pfizer’s COVID-19 vaccine, 7,673 cases to Moderna and 2,537 cases to Johnson & Johnson (J&J).
“The Centers for Disease Control and Prevention (CDC) today released new data showing a total of 1,307,928 reports of adverse events following COVID-19 vaccines were submitted between Dec. 14, 2020, and June 24, 2022, to the Vaccine Adverse Event Reporting System (VAERS). That’s an increase of 6,666 adverse events over the previous week.
VAERS is the primary government-funded system for reporting adverse vaccine reactions in the U.S.
The data included a total of 29,162 reports of deaths — an increase of 131 over the previous week — and 241,226 serious injuries, including deaths, during the same time period — up 1,004 compared with the previous week.
Of the 29,162 reported deaths, 18,885 cases are attributed to Pfizer’s COVID-19 vaccine, 7,673 cases to Moderna and 2,537 cases to Johnson & Johnson (J&J).
Excluding “foreign reports” to VAERS, 837,192 adverse events, including 13,463 deaths and 84,965 serious injuries, were reported in the U.S. between Dec. 14, 2020, and June 24, 2022.
Foreign reports are reports foreign subsidiaries send to U.S. vaccine manufacturers. Under U.S. Food and Drug Administration (FDA) regulations, if a manufacturer is notified of a foreign case report that describes an event that is both serious and does not appear on the product’s labeling, the manufacturer is required to submit the report to VAERS.
Of the 13,463 U.S. deaths reported as of June 22, 16% occurred within 24 hours of vaccination, 20% occurred within 48 hours of vaccination and 58% occurred in people who experienced an onset of symptoms within 48 hours of being vaccinated.
In the U.S., 593 million COVID-19 vaccine doses had been administered as of June 22, including 350 million doses of Pfizer, 224 million doses of Moderna and 19 million doses of Johnson & Johnson (J&J).
Every Friday, VAERS publishes vaccine injury reports received as of a specified date. Reports submitted to VAERS require further investigation before a causal relationship can be confirmed.
Historically, VAERS has been shown to report only 1% of actual vaccine adverse events.
U.S. VAERS data from Dec. 14, 2020, to June 24, 2022, for 6-month-olds to 5-year-olds show:
- 1,791 adverse events, including 64 cases rated as seriousand 3 reported deaths.
- 4 reportsof myocarditis and pericarditis (heart inflammation).The CDC uses a narrowed case definition of “myocarditis,” which excludes cases of cardiac arrest, ischemic strokes and deaths due to heart problems that occur before one has the chance to go to the emergency department.
- 13 reportsof blood clotting disorders.
U.S. VAERS data from Dec. 14, 2020, to June 24, 2022, for 5- to 11-year-olds show:
- 11,638 adverse events, including 300 rated as seriousand 7 reported deaths.
The most recent reported death (VAERS I.D. 2327226 ) occurred in an 8-year-old female from Texas who developed MIS-C [multi-system inflammatory syndrome] within one month of receiving her second dose of Pfizer.
Her VAERS report states:
“She developed inflamed lymph nodes (lymphadenitis), all over the body rash, ongoing fever for more than 3 weeks. She was diagnosed with MIS-C, her heart, intestines, lungs, skin and liver were inflamed. She was hospitalized and treated with immunoglobulin, steroids, anticoagulants, fever-reducing medications, etc. By the second treatment, her belly started getting distended, her lungs were filled with liquids. She was transferred to ICU and her heart stopped beating right there.”
- 23 reportsof myocarditis and pericarditis.The Defender has noticed over previous weeks that reports of myocarditis and pericarditis have been removed by the CDC from the VAERS system in this age group. No explanation was provided.
- 45 reportsof blood clotting disorders.
U.S. VAERS data from Dec. 14, 2020, to June 24, 2022, for 12- to 17-year-olds show:
- 32,472 adverse events, including 1,838 rated as seriousand 44 reported deaths.
- 62 reportsof anaphylaxis among 12- to 17-year-olds where the reaction was life-threatening, required treatment or resulted in death — with 97% of cases attributed to Pfizer’s vaccine.
- 654 reportsof myocarditis and pericarditis with 642 cases attributed to Pfizer’s vaccine.
There was one less case reported attributed to Pfizer’s vaccine since the previous week.
- 166 reportsof blood clotting disorders with all cases attributed to Pfizer. VAERS reported 167 cases of blood clotting disorders in the 12- to 17-year-old age group last week.
- 20 casesof postural orthostatic tachycardia syndrome (POTS) with all cases attributed to Pfizer’s vaccine.
U.S. VAERS data from Dec. 14, 2020, to June 24, 2022, for all age groups combined, show:
- 20% of deaths were related to cardiac disorders.
- 54% of those who died were male, 41% were female and the remaining death reports did not include the gender of the deceased.
- The average ageof death was 73.
- As of June 24, 5,611 pregnant womenreported adverse events related to COVID-19 vaccines, including 1,754 reports of miscarriage or premature birth.
- Of the 3,616 cases of Bell’s Palsyreported, 51% were attributed to Pfizer vaccinations, 40% to Moderna and 8% to J&J.
- 892 reports of Guillain-Barré syndrome, with 42% of cases attributed to Pfizer, 30% to Modernaand 27% to J&J.
- 2,286 reportsof anaphylaxis where the reaction was life-threatening, required treatment or resulted in death.
- 1,730 reportsof myocardial infarction.
- 14,148 reportsof blood-clotting disorders in the U.S. Of those, 6,325 reports were attributed to Pfizer, 5,078 reports to Moderna and 2,709 reports to J&J.
- 4,247 casesof myocarditis and pericarditis with 2,601 cases attributed to Pfizer, 1,444 cases to Moderna and 187 cases to J&J.
- 13 casesof Creutzfeldt-Jakob disease with 7 cases attributed Pfizer, 5 cases to Moderna and 1 case to J&J.
- 268 casesof POTS with 165 cases attributed to Pfizer, 84 cases to Moderna and 17 cases to J&J.